Senseonics announced today that it filed for CE mark for its Eversense 365 continuous glucose monitor (CGM) system.
RUTHERFORD, N.J. - Glucotrack, Inc. (NASDAQ: GCTK), a medical technology company, announced the successful completion of its first in human clinical study for a novel continuous glucose monitoring ...
For athletes with diabetes, continuous glucose monitors are game-changers, helping them avoid dangerous blood sugar crashes ...
New research suggests that wearing continuous glucose monitors could lower the risk of dementia. Experts discuss how symptoms ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results